Literature DB >> 15748910

The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.

Kimberly Forsten-Williams1, Ceres C Chua, Matthew A Nugent.   

Abstract

Binding of growth factors to specific cell surface receptors is the first step in initiating cell signaling cascades that ultimately result in diverse activities such as proliferation, differentiation, and apoptosis. Dimerization and phosphorylation of tyrosine kinase transmembrane receptors is the typical paradigm for this activation but, for many growth factors, cell surface interactions are not limited to a single receptor type. In particular, heparin-binding growth factors, such as fibroblast growth factor-2 (FGF-2), bind to heparan sulfate proteoglycans (HSPG) on the cell surface and within the extracellular matrix (ECM), and these molecules have been viewed as accessory co-receptors serving to facilitate tyrosine kinase receptor binding. Recent studies, however, have indicated that HSPG can directly participate in signal transduction in response to FGF-2 binding. Thus, in the present study, we used mathematical modeling to examine whether the kinetics of formation of the various FGF-2 bound complexes on the cell surface correlate with the activation of the downstream mediators of FGF-2 response, Erk1/2. We find that FGF-2 binding to its receptor correlates well with Erk1/2 activation and that HSPG can modulate this response through its ability to stabilize these ligand receptor complexes. Moreover, we also observed that FGF-2 binding to HSPG correlates strongly with Erk1/2 activation under conditions where there is a loss of receptor activity, and we demonstrate that the relative amounts of signaling and non-signaling HSPG on the cell surface, as well as the presence of competing HSPG in the ECM, can impact the signal potential via this pathway. Thus, the selective regulation of specific HSPG might provide a mechanism for fine tuned modulation of heparin-binding growth factor signaling in cells where signal intensity and duration could direct cellular response toward growth, migration or differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15748910     DOI: 10.1016/j.jtbi.2004.10.020

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  27 in total

Review 1.  Systems biology of the microvasculature.

Authors:  Lindsay E Clegg; Feilim Mac Gabhann
Journal:  Integr Biol (Camb)       Date:  2015-04-02       Impact factor: 2.192

2.  Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.

Authors:  Madelane Teran; Matthew A Nugent
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

3.  Matrix production and remodeling as therapeutic targets for uterine leiomyoma.

Authors:  Caitlin Fujisawa; John J Castellot
Journal:  J Cell Commun Signal       Date:  2014-07-11       Impact factor: 5.782

Review 4.  Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.

Authors:  Eric H Nguyen; William L Murphy
Journal:  Biomaterials       Date:  2018-07-26       Impact factor: 12.479

5.  Structure-activity relationship study of WSS25 derivatives with anti-angiogenesis effects.

Authors:  Xia Chen; Fei Xiao; Ying Wang; Jianping Fang; Kan Ding
Journal:  Glycoconj J       Date:  2012-07-31       Impact factor: 2.916

6.  Modulation of heparan sulfate biosynthesis by sodium butyrate in recombinant CHO cells.

Authors:  Payel Datta; Bo Yang; Robert J Linhardt; Susan T Sharfstein
Journal:  Cytotechnology       Date:  2014-01-29       Impact factor: 2.058

7.  Computational modeling with forward and reverse engineering links signaling network and genomic regulatory responses: NF-kappaB signaling-induced gene expression responses in inflammation.

Authors:  Shih Chi Peng; David Shan Hill Wong; Kai Che Tung; Yan Yu Chen; Chun Cheih Chao; Chien Hua Peng; Yung Jen Chuang; Chuan Yi Tang
Journal:  BMC Bioinformatics       Date:  2010-06-08       Impact factor: 3.169

8.  Endothelial cell capture of heparin-binding growth factors under flow.

Authors:  Bing Zhao; Changjiang Zhang; Kimberly Forsten-Williams; Jun Zhang; Michael Fannon
Journal:  PLoS Comput Biol       Date:  2010-10-28       Impact factor: 4.475

9.  Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.

Authors:  A H Palamakumbura; S R Vora; M A Nugent; K H Kirsch; G E Sonenshein; P C Trackman
Journal:  Oncogene       Date:  2009-07-13       Impact factor: 9.867

10.  A computational model of FGF-2 binding and HSPG regulation under flow.

Authors:  Wensheng Shen; Changjiang Zhang; Michael W Fannon; Kimberly Forsten-Williams; Jun Zhang
Journal:  IEEE Trans Biomed Eng       Date:  2008-07-15       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.